Vimicro International Corp. (NASDAQ:VIMC)‘s stock had its “buy” rating reaffirmed by equities research analysts at Needham & Company LLC in a research note issued to investors on Tuesday. They currently have a $13.00 target price on the stock. Needham & Company LLC’s price objective indicates a potential upside of 106.02% from the stock’s previous close. On Tuesday shares of Vimicro International Corp. (NASDAQ:VIMC) closed at $8.31. Company’s sales growth for last 5 years was -2.90% and EPS growth for next 5 years is recorded as 15.00%.
Marathon Oil Corporation (NYSE:MRO) said that it is expected to report earnings per share of $2.43 for the current fiscal year, as per consensus of analysts. Marathon Oil Corp (NYSE:MRO) reported last earnings figures on November 03rd. The company announced actual earnings per share of $0.56 against the consensus Street estimate of $0.59. This represents a year-on-year decrease of earning per share of $-0.07 from corresponding quarter of last year. Marathon Oil Corp posted revenue of $2.87 billion versus estimate of $2.98 billion. Marathon Oil Corporation (NYSE:MRO) in last trading activity moved down -1.33% to close at $25.89. Company weekly performance is -3.61% while its quarterly performance stands at -20.85%. Marathon Oil Corporation (NYSE:MRO) is -37.83% away from its 52 week high.
Haemonetics Corporation (NYSE:HAE) CEO Brian Concannon sold 4,765 shares of Haemonetics stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $37.20, for a total transaction of $177,258.00. Following the completion of the sale, the chief executive officer now directly owns 147,040 shares in the company, valued at approximately $5,469,888. On last trading day Haemonetics Corporation (NYSE:HAE) increased 0.44% to close at $38.50. Its volatility for the week is 1.81% while volatility for the month is 2.40%. HAE’s sales growth for past 5 years was 9.40% and its EPS growth for past 5 years was -9.90%. Haemonetics Corporation (NYSE:HAE) monthly performance is 4.08%.
On 5 January Intelligent Systems Corporation (NYSEMKT: INS) announced it has released ISS LM01, the company’s first standalone biometric and RFID access control terminal. Intelligent Systems Corporation (NYSEMKT: INS) has 35.72% insider ownership while its institutional ownership stands at 28.50%. In last trading activity company’s stock closed at $1.76.
ePlus inc. (NASDAQ:PLUS) CEO Phillip G. Norton sold 14,600 shares of the stock on the open market in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $66.47, for a total value of $970,462.00. Following the sale, the chief executive officer now directly owns 46,711 shares in the company, valued at approximately $3,104,880. ePlus inc. (NASDAQ:PLUS) has 6.10% insider ownership while its institutional ownership stands at 69.00%. In last trading activity company’s stock closed at $66.72.